Patent for Israel
- BioVentures
- May 29, 2020
- 1 min read
Updated: Nov 11, 2020
We have been informed by Israeli Patent Office that our patent application no 248011, concerning our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes is being processed. We are awaiting for further decisions.
コメント